世界中医药
文章摘要
引用本文:王楠楠1,周寒松1,顾新艳1,陈运2,陈言晓3.银杏二萜内酯葡胺注射液治疗缺血性脑卒中的临床效果[J].世界中医药,2021,(10):.  
银杏二萜内酯葡胺注射液治疗缺血性脑卒中的临床效果
Clinical Effects of Ginkgo Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke
投稿时间:2021-04-13  
DOI:10.3969/j.issn.1673-7202.2021.10.018
中文关键词:  银杏二萜内酯葡胺注射液  缺血性脑卒中  颈动脉斑块  静脉溶栓  中医  心脑血管疾病  言语功能  肢体功能
English Keywords:Ginkgo diterpene lactone meglumine Injection  Ischemic stroke  Carotid plaque  Intravenous thrombolysis  Traditional Chinese medicine  Cardiovascular and cerebrovascular diseases  Speech function  Limb function
基金项目:江苏省自然科学基金项目(BK20151108)
作者单位
王楠楠1,周寒松1,顾新艳1,陈运2,陈言晓3 1 江苏省淮安市第二人民医院,淮安,223001
2 江苏省淮安市中医院,淮安,223001
3 江苏省淮安市妇幼保健院,淮安,223001 
摘要点击次数: 246
全文下载次数: 0
中文摘要:
      目的:探讨银杏二萜内酯葡胺注射液治疗缺血性脑卒中的效果及对颈动脉斑块的影响。方法:选取2018年1月至2020年11月淮安市第二人民医院收治的缺血性脑卒中患者83例作为研究对象进行回顾性分析。根据用药方法不同分为对照组(n=42)和观察组(n=41)。对照组采取重组组织型纤溶酶原激活剂(rt-PA)溶栓治疗,观察组在对照组基础上给予银杏二萜内酯葡胺注射液。比较2组患者的治疗效果、神经功能、生命质量、炎症介质、颈动脉斑块情况、不良反应情况。结果:观察组的临床治疗效果优于对照组(P<0.05)。在治疗后,观察组的NIHSS评分、C反应蛋白(CRP)、白细胞介素-1β(IL-1β)、同型半胱氨酸(Hcy)、白细胞介素-2(IL-2)、颈动脉内膜-中层厚度、硬化斑块指数均低于对照组,Barthel指数高于对照组(P<0.05)。2组患者的不良反应发生率差异无统计学意义(P>0.05)。结论:在窗口期内顺利接受rt-PA溶栓治疗的缺血性脑卒中患者,给予银杏二萜内酯葡胺注射液进行联合治疗,可进一步提升治疗效果,改善神经功能以及生命质量,稳定血清学指标以及颈动脉斑块情况,治疗的安全性良好。
English Summary:
      To explore the effects of ginkgo diterpene lactone meglumine injection in the treatment of ischemic stroke and its effect on carotid plaque.Methods:A total of 83 patients with ischemic stroke treated in the Second People's Hospital of Huai'an City from January 2018 to November 2020 were retrospectively analyzed.According to different medication methods,they were divided into a control group(n=42)and an observation group(n=41).The control group was given thrombolytic therapy with recombinant tissue-type plasminogen activator(rt-PA),and the observation group was given Ginkgo diterpene lactone meglumine injection based on the treatment method of the control group.The treatment effect,nerve function,quality of life,inflammatory response factors,carotid artery plaque and adverse reactions of the 2 groups were compared.Results:The clinical effects of the observation group was better than that of the control group(P<0.05).After treatment,the NIHSS score,CRP,IL-1 β,Hcy,IL-2,carotid intima-media thickness and atherosclerotic plaque index of the observation group were lower than those of the control group,and Barthel index was higher than that of the control group(all P<0.05).There was no significant difference in the incidence of adverse reactions between the 2 groups(P>0.05).Conclusion:For patients with ischemic stroke who successfully received rt-PA thrombolytic therapy during the window period,the combined therapy with ginkgo diterpene lactone meglumine injection can further enhance the therapeutic effect,improve neurological function and quality of life,and stabilize serology Indicators and carotid plaque conditions,and the safety of treatment is good.
查看全文  查看/发表评论  下载PDF阅读器